hopeful hearts therapy, lcsw, pLLC

250 e 63rd st apt 212
new york, new york, 10065

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 07, 2014

NYS DOS ID#
4573238

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY

Name History
2014 - HOPEFUL HEARTS THERAPY, LCSW, PLLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • First genetic engineering therapy approved by the FDA for leukemia
    By Beth Mole - Wednesday Aug 30, 2017

    Safety risks still an issue for the CAR-T therapy, but new hope for young patients.

    Source: Ars Technica
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Boston Is Arguably the Heart of Biotech. But Who Makes It So? Have Your Say.
    By Ben Fidler - Monday Jun 26, 2017

    By the end of this year, for the first time, patients with certain deadly types of blood cancer might have a new option, CAR-T cell therapy, to prolong their life. Immunotherapy could further entrench itself as a mainstay of cancer treatment. Newer drugmaking methods—RNA interference and gene therapy—could get their first ever FDA reviews. Multiple […]

    Source: Xconomy New York
  • 'Beating Heart' Patch Offers New Hope for Desperately Ill Patients
    By David Cox - Thursday Aug 24, 2017

    Researchers are using stem cells to fabricate tiny patches they hope will be able to restore function to damaged cardiac tissue.

    Source: NBC News